![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Zoha Hajikhani, Ismaeil Haririan, Mohammad Akrami & Saba Hajikhani. (2023) Nanoarchitectonics of Doxycycline-Loaded Vitamin E–D-α-Tocopheryl Polyethylene Glycol 1000 Succinate Micelles for Ovarian Cancer Stem Cell Treatment. Nanomedicine 18:21, pages 1441-1458.
Read now
Read now
Yongxu Chen, Wei Tan & Changjun Wang. (2018) Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial–mesenchymal transition. OncoTargets and Therapy 11, pages 3817-3826.
Read now
Read now
Articles from other publishers (21)
Anna Tosi, Beatrice Parisatto, Enrico Gaffo, Stefania Bortoluzzi & Antonio Rosato. (2024) A paclitaxel-hyaluronan conjugate (ONCOFID-P-B™) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment. Journal of Experimental & Clinical Cancer Research 43:1.
Crossref
Crossref
Yiqi Duan & Xiao Xu. (2023) A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer. Frontiers in Endocrinology 14.
Crossref
Crossref
Huiying Ma, Tian Tian & Zhumei Cui. (2023) Targeting ovarian cancer stem cells: a new way out. Stem Cell Research & Therapy 14:1.
Crossref
Crossref
Natalia Izycka, Marcin Rucinski, Malgorzata Andrzejewska, Sebastian Szubert, Ewa Nowak-Markwitz & Karolina Sterzynska. (2023) The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients. International Journal of Molecular Sciences 24:3, pages 2400.
Crossref
Crossref
Douglas D. Fang, Ran Tao, Guangfeng Wang, Yuanbao Li, Kaixiang Zhang, Chunhua Xu, Guoqin Zhai, Qixin Wang, Jingwen Wang, Chunyang Tang, Ping Min, Dengkun Xiong, Jianyong Chen, Shaomeng Wang, Dajun Yang & Yifan Zhai. (2022) Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models. BMC Cancer 22:1.
Crossref
Crossref
Luyao Wang, Xiaogai Zhi, Yingying Lu, Yu Cong, Ziyi Fu, Jian Cao, Sujuan Xu, Juan Lv & Hongjie Ruan. (2022) Identification of microRNA expression profiles of CD44+ ovarian cancer stem cells. Archives of Gynecology and Obstetrics 306:2, pages 461-472.
Crossref
Crossref
Xiwei Wang, Yanmei Zhang, Xiaofeng Mu, Chloe Ran Tu, Yuet Chung, Sai Wah Tsao, Godfrey Chi-Fung Chan, Wing-Hang Leung, Yu-lung Lau, Yinping Liu & Wenwei Tu. (2022) Exosomes derived from γδ-T cells synergize with radiotherapy and preserve antitumor activities against nasopharyngeal carcinoma in immunosuppressive microenvironment. Journal for ImmunoTherapy of Cancer 10:2, pages e003832.
Crossref
Crossref
Kristin L. M. Boylan, Somaieh Afiuni-Zadeh, Melissa A. Geller, Peter A. Argenta, Timothy J. Griffin & Amy P. N. Skubitz. (2021) Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics. Clinical Proteomics 18:1.
Crossref
Crossref
Wookyeom Yang, Dasol Kim, Dae Kyoung Kim, Kyung Un Choi, Dong Soo Suh & Jae Ho Kim. (2021) Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells. International Journal of Molecular Sciences 22:10, pages 5059.
Crossref
Crossref
Ketaki Kar, Suman Ghosh & Anup Kumar Roy. (2021) A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67. Journal of Laboratory Physicians 13:01, pages 050-057.
Crossref
Crossref
Mohammad Mahmoudi Gomari, Marziye Farsimadan, Neda Rostami, Zahra mahmoudi, Mahmood Fadaie, Ibrahim Farhani & Parastoo Tarighi. (2021) CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations. Mutation Research/Reviews in Mutation Research 787, pages 108374.
Crossref
Crossref
Marie Christine Wulff Westergaard, Katy Milne, Magnus Pedersen, Thomas Hasselager, Lars Rønn Olsen, Michael S. Anglesio, Troels Holz Borch, Mia Kennedy, Gillian Briggs, Stacey Ledoux, Caroline Kreuzinger, Isabel von der Decken, Marco Donia, Dan Cacsire Castillo-Tong, Brad H. Nelson & Inge Marie Svane. (2020) Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer. Cancers 12:12, pages 3828.
Crossref
Crossref
Hanxiao Xu, Mengke Niu, Xun Yuan, Kongming Wu & Aiguo Liu. (2020) CD44 as a tumor biomarker and therapeutic target. Experimental Hematology & Oncology 9:1.
Crossref
Crossref
Bit Na Kim, Dong Hyuck Ahn, Nahyeon Kang, Chang Dong Yeo, Young Kyoon Kim, Kyo Young Lee, Tae-Jung Kim, Sug Hyung Lee, Mi Sun Park, Hyeon Woo Yim, Jong Y. Park, Chan Kwon Park & Seung Joon Kim. (2020) TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer. Scientific Reports 10:1.
Crossref
Crossref
Sandra Muñoz-Galván & Amancio Carnero. (2020) Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer. Cells 9:6, pages 1402.
Crossref
Crossref
Rossella Farra, Matea Maruna, Francesca Perrone, Mario Grassi, Fabio Benedetti, Marianna Maddaloni, Maguie El Boustani, Salvo Parisi, Flavio Rizzolio, Giancarlo Forte, Fabrizio Zanconati, Maja Cemazar, Urska Kamensek, Barbara Dapas & Gabriele Grassi. (2019) Strategies for Delivery of siRNAs to Ovarian Cancer Cells. Pharmaceutics 11:10, pages 547.
Crossref
Crossref
Xingyue Zong & Kenneth P. Nephew. (2019) Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting. Cancers 11:7, pages 934.
Crossref
Crossref
Jin Zhang, Baozhu Yuan, Huidan Zhang & Hongxia Li. (2019) Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance. Oncology Letters.
Crossref
Crossref
Zalitha Pieterse, Monica Angelica Amaya-Padilla, Terence Singomat, Mudra Binju, Bau Dilam Madjid, Yu Yu & Pritinder Kaur. (2019) Ovarian cancer stem cells and their role in drug resistance. The International Journal of Biochemistry & Cell Biology 106, pages 117-126.
Crossref
Crossref
Na Li, Huanni Li, Lanqin Cao & Xianquan Zhan. (2018) Quantitative analysis of the mitochondrial proteome in human ovarian carcinomas. Endocrine-Related Cancer 25:10, pages 909-931.
Crossref
Crossref
Claire Henry, Neville Hacker & Caroline Ford. (2017) Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis. Oncotarget 8:68, pages 112727-112738.
Crossref
Crossref